- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00986375
Online Program Assisting Lifestyle Changes (Asterix 1.0 & Obelix 2.0) (OPAL)
Online Program Assisting Lifestyle Changes: Adopting and Maintaining Physical Activity and Fruit & Vegetable Consumption (Asterix 1.0 & Obelix 2.0)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Two experimental studies are planned over a time period of 12 weeks. In the nutrition study, participants will randomly be allocated to either a waiting control group (WCG) receiving a tailored intervention after the last follow-up questionnaire, an active control group (ACG), receiving an interactive quiz on all areas of healthy nutrition or to one of two intervention groups (IGs). Intervention group 1 receives one of four computerized tailored interventions based on a standard recommendation on vegetable and fruit intake, intervention group 2 receives one of the same four tailored interventions based on another criterion.
In the physical activity study, study participants in the intervention group receive an interactive, computerized expert system (Intervention Group, IG). Individuals in the Active Control Group (ACG) get a standard program, which does not tailor treatment components to the individual needs of the patients. Internet users (N = 1000) will be recruited in in the internet via press releases, personal invitations and advertised likes at well known web-sites. Study participants will be followed up over three measurement points: One to eight weeks after T1, T2 will take place. Four to 12 weeks after T1 the T3 measurement will be conducted.
The hypotheses are: Both the IG and the ACG are expected to have a higher motivation, to adopt a healthy lifestyle, to perform more health behavior and to be less likely to relapse into previous unhealthy routines at T2 and T3 than at T1. Also, IG and ACG will be healthier as well as they will report more quality of life and rehabilitation satisfaction at T2 and T3 than at T1. In comparison to ACG, the IG is hypothesized to be more effective than the ACG regarding motivation, behavior and social-cognitive predictors of behavior. Moreover, the interventions (ACG and IG) are supposed to be equally effective for different age and sex groups, obese and non-obese individuals. In the nutrition study, the IG2 will report higher on all outcome measures than IG1.
After successful evaluation and some adoptions the intervention will be implemented as a self-help program in all eligible Internet users in the Internet.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 14195
- Freie Universitaet Berlin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- to be capable of exercising on their own at a minimum level and/or to consume fruits and vegetables
- able to fill out a questionnaire (no illiteracy)
- adequate German language ability
Exclusion Criteria:
- no internet access
- no computer with keyboard
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group (IG)
Patients in the IG will receive an interactive, computerized expert system which tailors treatment components to the individual needs of the patients
|
patients will receive an interactive, computerized expert system which tailors treatment components to the individual needs of the patients
|
ACTIVE_COMPARATOR: Active Control Group (ACG)
Patients in the ACG will get an interactive computerized standard program
|
Patients in the ACG will get an interactive computerized standard program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
physical activity fruit & vegetable consumption
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
subjective health & well-being
Time Frame: 12 weeks
|
12 weeks
|
motivation/volition
Time Frame: 12 weeks
|
12 weeks
|
social-cognitive predictors of behavior (self-efficacy, action control etc.)
Time Frame: 12 weeks
|
12 weeks
|
intervention engagement
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ralf Schwarzer, PhD, Freie Universitaet Berlin
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FU-10-4711-001
- Asterix_1.0
- Obelix_2.0
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
Clinical Trials on Intervention Group (IG)
-
European Institute of OncologyIstituto Nazionale Tumori IRCCS - Fondazione G. PascaleRecruitingProstate CancerItaly
-
Universidad de CórdobaUnknownOverweight and Obesity | Signs and Symptoms | Behavior, EatingSpain
-
Universiti Putra MalaysiaNot yet recruitingCardiometabolic SyndromeMalaysia
-
Medipol UniversityCompleted
-
Universidad de CórdobaUnknown
-
Washington University School of MedicineSpinal Cord Injury/Disease Research ProgramCompleted
-
Hospital Universitario Virgen MacarenaCompletedPulmonary Rehabilitation | Non-cystic Fibrosis BronchiectasisSpain
-
Freie Universität BerlinDeutsche RentenversicherungCompletedHeart Diseases | Pain | Diabetes Mellitus, Type 2 | Osteoarthritis | Rheumatoid Arthritis | Motivation | BehaviorGermany
-
Freie Universität BerlinBoehringer IngelheimCompletedHeart Diseases | Diabetes Mellitus, Type 2 | Motivation | BehaviorGermany
-
Viviane de Souza Pinho CostaCompletedVestibular Diseases